Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00311-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Junchao Lou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Antimalarials, Anopheles, Plasmodium falciparum, Plasmodium berghei. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
The emergence of clinically drug-resistant malaria parasites requires the urgent development of new drugs. Mosquitoes are vectors of multiple pathogens and have developed resistance mechanisms against them, which often involve antimicrobial peptides (AMPs). An-cecB is an AMP of the malaria-transmitting mosquito genus Anopheles , and we herein report its antimalarial activity against Plasmodium falciparum 3D7, the artemisinin-resistant strain 803, and the chloroquine-resistant strain Dd2 in vitro . We also demonstrate its anti-parasite activity in vivo , using the rodent malaria parasite Plasmodium berghei (ANKA). We show that An-cecB displays potent antimalarial activity and that its mechanism of action may occur through direct killing of the parasite or through interaction with infected red blood cell membranes. Unfortunately, An-cecB was found to be cytotoxic to mammalian cells and had poor antimalarial activity in vivo . However, its truncated peptide An-cecB-1 retained most of its antimalarial activity and avoided its cytotoxicity in vitro . An-cecB-1 also showed better antimalarial activity in vivo . Mosquito-derived AMPs may provide new ideas for the development of antimalarial drugs against drug-resistant parasites, and An-cecB has potential use as a template for antimalarial peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
- National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, China.
- Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
ORCID-Profile: Jingyao Wu, Xiaoqin He, Jun Cao
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
Zitieren
APA
Lou, J., Zhang, D., Wu, J., Zhu, G., Zhang, M., Tang, J., Fang, Y., He, X., & Cao, J. (2024). Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00311-24
Vancouver
Lou J, Zhang D, Wu J, Zhu G, Zhang M, Tang J, et al. Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00311-24
BibTeX
@article{Lou2024,
author = {Lou, Junchao and Zhang, Dongying and Wu, Jingyao and Zhu, Guoding and Zhang, Meihua and Tang, Jianxia and Fang, Yaqun and He, Xiaoqin and Cao, Jun},
title = {Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00311-24}
}
EUVIMED